ArticleMSMR2026
Trends in postpartum depression and anxiety diagnoses among U.S. active component service women, 2010-2024.
Article in MSMR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This retrospective cohort study evaluated trends in postpartum depression (PPD) and postpartum anxiety (PPA) diagnoses among 138,588 active component service women with live births (2010-2024). Period prevalence of PPD/PPA remained relatively constant from 2010 to 2017 (2.4%) and began increasing in 2018, with a peak in 2022 (13.4%). Multivariable logistic regression (2021-2024) demonstrated a statistically significant decrease in adjusted odds of PPD/PPA diagnosis in 2023-2024 (adjusted odds ratio 0.89), following the pandemic peak. The most significant risk factors for PPD/PPA diagnosis were prior mental health history, service in the Navy, and cesarean delivery. The 15-year increase in diagnostic prevalence may reflect improved administrative documentation and reduced stigma associated with seeking care. Conversely, the post-2022 decline may reflect post-pandemic stabilization and mitigating effects of expanded parental leave. Current PPD/PPA prevalence remains higher than pre-pandemic proportions, however. Prior mental health diagnosis remains the critical predictor, identifying a key population requiring targeted support to enhance military readiness. Period prevalence of PPD/PPA peaked in 2022 before declining in 2023 and 2024, while remaining higher than pre-pandemic levels. Service in the Navy, prior mood disorders, and cesarean delivery correlated with increased diagnostic odds, while Air Force and Space Force service, as well as officer status, were associated with reduced odds compared to Army and enlisted personnel.
Indexed as
Identifiers
42748331PMC13645438What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.